Last reviewed · How we verify

NCT05396430

Duration of Urinary Catheter Treatment After Cesarean Delivery Under Spinal Anesthesia

Status unknown NA Last updated 26 April 2023
What this trial tests

NA trial testing Urinary catheter in Urinary Retention in 150 participants. Status unknown.

Timeline
1 January 2023
Primary endpoint
31 August 2023
31 August 2023

Quick facts

Lead sponsorWomen's Hospital HUS
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment150
Start date1 January 2023
Primary completion31 August 2023
Estimated completion31 August 2023
Sites1 location across Finland

Drugs / interventions tested

Conditions studied

Sponsor

Women's Hospital HUS

Who can join

Adults 18 to 55, female only, with Urinary Retention or Cesarean Section Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study a total of 150 parturients undergoing cesarean delivery under spinal anesthesia will be randomized to have their urinary catheters kept in place for 8, 10 or 12 hours. The incidence of urinary retention and interventions needed for any potential urinary retention will be assessed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Urinary catheter

Trials testing the same drug.

Other recruiting trials for Urinary Retention

Currently open trials in the same condition.

Other Women's Hospital HUS trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05396430.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing